Loading...
•
Jun 30, 2022
ClearPoint Neuro Q2 2022 Earnings Report
Reported record quarterly revenue and biologics and drug delivery business led the way.
Key Takeaways
ClearPoint Neuro reported a record quarterly revenue of $5.2 million, a 52% year-over-year increase. The biologics and drug delivery business became the largest segment with product and service revenue growing at more than 70%. The company reaffirmed its full year 2022 revenue outlook of between $21.0 and $22.0 million.
Reported record quarterly revenue of $5.2 million, a 52% year-over-year increase.
Increased biologics and drug delivery revenue to $2.4 million, a 73% year-over-year increase.
Added multiple new biologics and drug delivery partners in the quarter to bring the total to more than 45.
Installed four additional systems in the quarter bringing the total to 8 new installations year-to-date.
Revenue by Segment
Forward Guidance
The Company reaffirms its full year 2022 revenue outlook of between $21.0 and $22.0 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...